John Doherty serves as Chief Financial Officer at Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming medical imaging with its revolutionary handheld, whole-body ultrasound devices. With more than 25 years of experience in finance leadership within the healthcare, medical device, and technology sectors, Doherty has a proven track record of steering companies through growth, mergers, and public market transitions. His expertise encompasses strategic financial planning, capital raising, operational efficiency, and global scaling. Prior to joining Butterfly in October 2021, Doherty was CFO at ViewRay, Inc., where he oversaw financial operations during the commercialization of innovative MR-guided radiation therapy systems and managed the company's path through Chapter 11 restructuring. Before that, he held the CFO role at Syneron Candela, directing global finance amid acquisitions and product launches, and served as Vice President of Finance at Hologic, Inc., contributing to diagnostics portfolio expansions. Earlier in his career, Doherty spent over a decade at Deloitte Consulting, advising healthcare clients on transformative initiatives. At Butterfly Network, Doherty leads all financial functions, including investor relations, treasury, and compliance, supporting the company's mission to democratize ultrasound worldwide. His strategic oversight has been instrumental in post-SPAC execution, revenue growth exceeding 20% year-over-year, and securing key partnerships and funding to fuel R&D and market expansion. Doherty's leadership continues to position Butterfly as a leader in accessible, AI-powered medical imaging.